Cocrystal Pharma, Inc. Common Stock (COCP) is a publicly traded Healthcare sector company. As of May 21, 2026, COCP trades at $1.13 with a market cap of $16.27M and a P/E ratio of -1.42. COCP moved -2.61% today. Year to date, COCP is +1.83%; over the trailing twelve months it is -26.73%. Its 52-week range spans $0.86 to $3.26. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces COCP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
COCP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COCP recently traded at $1.13. Market cap is $16.27M. P/E ratio is -1.42. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.13 |
| Market Cap | $16.27M |
| P/E Ratio | -1.42 |
| EPS | $-0.78 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.26 |
| 52-Week Low | $0.86 |
| Volume | 27 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.83M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-8.83M | $-0.78 |
| 2024 | $0 | $-17.50M | $-1.72 |
| 2023 | $0 | $-17.98M | $-1.87 |
| 2022 | $0 | $-38.84M | $-4.77 |
1 analysts cover COCP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.